GIA
ADVM

GHP Investment Advisors’s Adverum Biotechnologies ADVM Stock Holding History

GHP Investment Advisors’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20
Closed -$91 – 986
2025
Q3 		$91 Hold
20
– – ﹤0.01% 932
2025
Q2 		$43 Hold
20
– – ﹤0.01% 938
2025
Q1 		$88 Hold
20
– – ﹤0.01% 940
2024
Q4 		$94 Hold
20
– – ﹤0.01% 967
2024
Q3 		$141 Hold
20
– – ﹤0.01% 956
2024
Q2 		$138 Hold
20
– – ﹤0.01% 953
2024
Q1 		$283 Hold
20
– – ﹤0.01% 813
2023
Q4 		$151 Hold
20
– – ﹤0.01% 828
2023
Q3 		$196 Hold
20
– – ﹤0.01% 919
2023
Q2 		$378 Hold
20
– – ﹤0.01% 896
2023
Q1 		$144 Hold
20
– – ﹤0.01% 904
2022
Q4 		$116 Hold
20
– – ﹤0.01% 914
2022
Q3 		$0 Hold
20
– – ﹤0.01% 894
2022
Q2 		$0 Hold
20
– – ﹤0.01% 911
2022
Q1 		$0 Buy
+20
New +$293 ﹤0.01% 934

GHP Investment Advisors's ADVM Position: Q4 2025 in Review

GHP Investment Advisors sold out of Adverum Biotechnologies (ADVM) in Q4 2025, closing a stake of 20 shares — an estimated $91 sold.

GHP Investment Advisors first reported a position in ADVM in Q1 2022 and held it in 15 quarters. The position peaked at $378 in Q2 2023. 0 funds tracked by Wall St. Rank hold ADVM as of Q4 2025.

  • GHP Investment Advisors reported no remaining Adverum Biotechnologies position as of Q4 2025 after selling out during the quarter.
  • GHP Investment Advisors sold 20 Adverum Biotechnologies shares in Q4 2025, an estimated $91.
  • GHP Investment Advisors first reported a position in Adverum Biotechnologies in Q1 2022 and held it in 15 quarters.
  • GHP Investment Advisors's Adverum Biotechnologies position peaked at $378 in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2025.

Based on GHP Investment Advisors's 13F filing for Q4 2025, filed 27 Jan 2026.